Premium
News from the American Heart Association: more on sodium–glucose co‐transporter 2 inhibitors, diabetes and heart failure
Author(s) -
Coats Andrew J.S.,
Seferović Petar M.
Publication year - 2019
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.1429
Subject(s) - dapagliflozin , medicine , empagliflozin , mace , timi , heart failure , placebo , clinical trial , diabetes mellitus , clinical endpoint , type 2 diabetes , randomized controlled trial , intensive care medicine , percutaneous coronary intervention , myocardial infarction , endocrinology , alternative medicine , pathology